Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (16)
  • Antithrombotics (219)
    • Drug-Induced Thrombosis (23)
    • Prevention (32)
    • Reversal (14)
    • Treatment (183)
      • Apixaban (Eliquis) (34)
      • Aspirin (77)
      • Clopidogrel (Plavix) (53)
      • Dabigatran (Pradaxa) (51)
      • Edoxaban (Savaysa) (12)
      • Low Molecular Weight Heparins (40)
      • Other (27)
      • Prasugrel (Effient) (23)
      • Rivaroxaban (Xarelto) (38)
      • Ticagrelor (Brilinta) (20)
      • Vorapaxar (Zontivity) (2)
      • Warfarin - Drug Interactions (32)
      • Warfarin - Treatment (68)
  • Arrhythmias (115)
  • Blood Pressure (36)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (88)
  • Dyslipidemia (220)
  • Endocarditis (17)
  • Heart Disease (69)
  • Heart Failure (155)
  • Hypertension (226)
  • Hypotension (15)
  • Ischemic Heart Disease/Acute Coronary Syndromes (272)
  • Myocardial Infarction (40)
  • Peripheral Vascular Disease (5)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (2)
  • Resources (666)
  • Stroke (114)
46 - 60 of 183 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Expedite Prior Auths for Lower Doses of Eliquis and Xarelto June 2017
Patient Education: Fish Oil and Other Omega-3 Fatty Acids May 2017
Toolbox: Drug Interactions: A Practical Approach February 2017
Article: Watch for Statin Interactions With Pradaxa February 2017
Chart: Safety Comparison of NSAIDs January 2017
Chart: Anticoagulants in Pregnancy December 2016
Article: Watch for Heart Patients on Aspirin Who Are at Risk for GI Bleeds November 2016
Article: Find Out WHY Patients Are Taking Blood Thinners October 2016
Article: Be Careful with Enoxaparin's SEVEN Strengths July 2016
Technician Tutorial: Injectable Anticoagulants July 2016
Article: Expedite Requests for Reduced Doses of DOACs (Pradaxa, etc) May 2016
Patient Education: What You Should Know About Proton Pump Inhibitors March 2016
Article: Think of Durlaza as an Expensive Way to Get Low-Dose Aspirin December 2015
Commentary: New Formulation: Durlaza (Aspirin Extended-Release) December 2015
Article: Help Ensure Your Pradaxa Patients Don't Need the New Reversal Agent, Praxbind December 2015
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved